NCT03219632View on ClinicalTrials.gov

Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

June 5, 2012

Primary Completion Date

April 30, 2017

Study Completion Date

May 30, 2017

Conditions
Left Ventricular HypertrophyHypertension
Interventions
DRUG

Fimasartan

Fimasartan is a non-peptide angiotensin II receptor antagonist (ARB) used for the treatment of hypertension and heart failure.

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER

NCT03219632 - Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG | Biotech Hunter | Biotech Hunter